Jaguar Health (JAGX) Return on Invested Capital (2019 - 2023)

Jaguar Health (JAGX) reported Return on Invested Capital of 0.05% for Q2 2023, up 49.79% quarter-over-quarter from 0.1% in Q1 2023.

Jaguar Health (JAGX) Return on Invested Capital (2019 - 2023) Analysis & Trends

Jaguar Health (JAGX) has 2 years of Return on Invested Capital data on file, last reported at 0.05% in Q2 2023.

Return on Invested Capital for Q2 2023 came in at 0.05%, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was 0.05% (changed N/A YoY), and the FY2019 annual result was 0.04%, changed N/A from the prior year.
Return on Invested Capital advanced to 0.05% in Q2 2023 per JAGX's latest filing, from 0.1% in the prior quarter.
Over five years, Return on Invested Capital peaked at 0.02% in Q4 2019 and troughed at 0.1% in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-	-
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn	0.01%
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-	-0.01%
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-	-0.01%
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-	-
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn	0.00%
9	Abivax	94.26 Bn	94.26 Bn	-	-
10	Jaguar Health	1.44 Mn	-10.19 Mn	19.11 Mn	-

Download Data